Table 1.
Patient Characteristics.
| Characteristics | Value | ||
|---|---|---|---|
| Median Age | 51.7 (27.3–69.8) | ||
| Male, n (%) | 16 (80) | ||
| Diagnosis/Disease status | |||
| AML | 6 | ||
| Refractory | 2 | ||
| CR1 | 2 | ||
| CRi | 2 | ||
| Plasmacytoid dendritic neoplasm | 1 | ||
| ALL | 2 | ||
| Refractory | 1 | ||
| CR2 | 1 | ||
| CMML | 2 | ||
| Refractory | 2 | ||
| Non-Hodgkin Lymphoma | 9 | ||
| CR1 | 2 | ||
| CR2 | 1 | ||
| CR3 | 1 | ||
| Refractory | 5 | ||
| Disease risk | |||
| Low | 1 (5%) | ||
| Intermediate | 11 (55%) | ||
| High | 6 (30%) | ||
| Very High | 2 (10%) | ||
| Comorbidity Index | |||
| Low (0) | 7 (35%) | ||
| Intermediate (1–2) | 6 (30%) | ||
| High (>=3) | 7 (35%) | ||
| Donor Type | MRD | 9 (45%) | |
| MURD | 9 (45%) | ||
| Mismatch | 2 (10%) |